[1]
R. Ghali, “Resistance Studies, in vitro Model, of Myeloid Leukemia Cell Lines HL-60 Against Thymoquinone and Doxorubicin in the Presence of Type I Collagena”, J. Hematol. Res., vol. 4, pp. 1–8, Feb. 2017.